Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/1992
01/22/1992EP0467782A1 Myocardial infarction immunoassay
01/22/1992EP0467701A2 Cyclic HIV principal neutralizing determinant peptides
01/22/1992EP0467699A2 Cyclic HIV principal neutralizing determinant peptides
01/22/1992EP0467676A2 Temperature-inducible secretion expression vectors and their use in prokaryotic cells
01/22/1992EP0467536A2 Method of treating bladder cancer cells
01/22/1992EP0467366A2 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents
01/22/1992EP0466995A2 Sucrose phosphate synthase (SPS), its process for preparation, its cDNA, and utilization of cDNA to modify the expression of SPS in the plant cells
01/22/1992EP0466854A1 T cell growth factor
01/22/1992EP0466817A1 Recombinant trichosanthin and coding sequence
01/22/1992EP0466806A1 Phosphatidylinositol linking of proteins
01/22/1992EP0466780A1 Megakaryocyte growth promoting activity
01/22/1992CN1058045A Cephalosporin acetylhydrolase gene and protein encoded by said gene
01/22/1992CN1058044A Method of preparing plasmid having both expressing ability of retrovial gene and processing ability after translation, and resultant plasmid and expression products thereof
01/21/1992US5082967 Novel fatty acid analog enzyme substrates
01/21/1992US5082783 Genetic engineering, biosynthesis
01/21/1992US5082776 Method of producing an adult t cell leukemia virus fused antigen polypeptide
01/21/1992US5082773 Biosynthesis
01/21/1992US5082672 Enzymatic deamidation of food proteins for improved food use
01/21/1992CA1294570C Monoclonal antibodies specifically directed against prosomal proteins
01/20/1992WO1992001472A1 Multivalent anti-cytokine immunoglobulins
01/20/1992WO1992001464A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs
01/20/1992CA2087541A1 Multivalent anti-cytokine immunoglobulins
01/20/1992CA2087169A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs
01/20/1992CA2047078A1 Cyclic hiv principal neutralizing determinant peptides
01/20/1992CA2047043A1 Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties
01/20/1992CA2047042A1 Cyclic hiv principal neutralizing determinant peptides
01/20/1992CA2047033A1 Cyclic hiv principal neutralizing determinant peptides
01/20/1992CA2047030A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties
01/20/1992CA2045231A1 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents
01/19/1992WO1992001808A1 Reagent for diagnosing mycoplasma pneumoniae
01/19/1992CA2073861A1 Diagnostic reagent for mycoplasma pneumoniae
01/19/1992CA2047298A1 Myocardial infarction immunoassay
01/19/1992CA2046754A1 Dna coding for a human vasoconstrictive peptide and use thereof
01/18/1992WO1992001781A1 Antibody-mediated cofactor-driven reactions
01/18/1992CA2086755A1 Antibody-mediated cofactor-driven reactions
01/17/1992WO1992001797A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA)
01/17/1992CA2084189A1 Immunoglobulin production by trichoderma
01/17/1992CA2047091A1 Method for producing gene protein products
01/17/1992CA2045842A1 Dna capable of site-specific integration into mycobacteria
01/15/1992EP0466505A2 Artificial antibody
01/15/1992EP0466251A1 Elfamycin-resistant mutants
01/15/1992EP0466222A1 Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
01/15/1992EP0466204A1 Novel polypeptides, DNAs that code for the same, and method of preparing said polypeptides and DNAs
01/15/1992EP0466199A1 Polypeptide fragments of factor VIIIc, corresponding probes and DNA sequences and DNA constructs
01/15/1992EP0466175A1 Porcine CNP gene and precursor protein
01/15/1992EP0465979A1 Anti HTLV-III (strain MN) monoclonal antibody
01/15/1992EP0465895A1 WS7622A di- sulfate, process for preparation thereof and use thereof
01/15/1992EP0465633A1 C4 binding protein fusion proteins
01/15/1992EP0465602A1 METHOD FOR DETECTION AND/OR IDENTIFICATION OF $i(LYSSAVIRUS) INFECTIONS, CLONING AND EXPRESSION OF GENES CODING FOR PEPTIDES AND/OR FRAGMENTS OF PEPTIDES OF MOKOLA $i(LYSSAVIRUS), VACCINE AGAINST THE MOKOLA VIRUS AND/OR THE FAMILY OF $i(LYSSAVIRUSES) AS WELL AS METHOD FOR OBTAINING SAID VACCINE VIA
01/15/1992EP0465539A1 Vaccinia vectors, vaccinia genes and expression products thereof
01/15/1992EP0235162B1 Cdna and gene for human angiogenin (angiogenesis factor) and methods of expression
01/15/1992CN1057862A Muteins of granulocyte colony stimulating factor
01/15/1992CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof
01/15/1992CN1057784A Growth hormone releasing factor analogs
01/14/1992WO1992001053A1 Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same
01/14/1992WO1992001039A1 Promotion of maturation of hematopoietic progenitor cells
01/14/1992US5081235 Chimeric anti-cea antibody
01/14/1992US5081225 Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum
01/14/1992US5081034 Genetic engineering
01/14/1992US5081032 Anti-human pulmonary adenocarcinoma monoclonal antibody
01/14/1992US5081028 Preparation of transformed hosts which express binding factor related polypeptides
01/14/1992US5081022 Vector for the cloning and expression of γ-interferon, transformed bacteria and process for the preparation of γ-interferon
01/14/1992US5081018 Murine autonomous replication sequences and vectors containing
01/14/1992US5081010 Alcoholamine, ethylene oxide alkylphenol compound; medical diagnosis
01/14/1992CA2087170A1 Promotion of maturation of hematopoietic progenitor cells
01/14/1992CA1294233C Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody
01/14/1992CA1294232C Process for preparing glucagon or derivatives or fragments thereof in yeast
01/14/1992CA1294231C Method of producing peptides
01/14/1992CA1294215C Pharmaceutical compositions of recombinant beta-interferon and formulation processes
01/13/1992WO1992001051A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof
01/13/1992CA2087005A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof
01/12/1992WO1992000985A1 Streptomyces vectors for production of heterologous proteins
01/12/1992CA2087017A1 Streptomyces vectors for production of heterologous proteins
01/11/1992WO1992001055A1 O-glycosylated ifn-alpha
01/11/1992WO1992001043A1 Hybridoma which produces avian specific immunoglobulin g
01/11/1992CA2084514A1 O-glycosylated ifn-alpha
01/11/1992CA2066433A1 Chicken-specific immunoglobulin g-producing hybridoma
01/09/1992WO1992000387A1 Neurofibromatosis gene
01/09/1992WO1992000383A1 Antibodies specific for the transglutaminase-induced isopeptide bond
01/09/1992WO1992000382A1 Gdf-1
01/09/1992WO1992000377A1 Glyphosate tolerant plants
01/09/1992WO1992000376A1 Mast cell growth factor
01/09/1992WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
01/09/1992WO1992000329A1 Surface complexed lymphotoxin
01/09/1992WO1992000327A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a)
01/09/1992WO1992000326A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(b)
01/09/1992WO1992000321A1 Novel, protracted insulin analogues
01/09/1992WO1992000311A1 Probes for detecting mutant p53
01/09/1992WO1992000092A1 Ligand for cd28 receptor on b cells and methods
01/09/1992WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
01/09/1992WO1992000055A1 Compositions and methods for the prevention and diagnosis of lyme disease
01/09/1992CA2086334A1 Neurofibromatosis gene
01/09/1992CA2086091A1 Human macrophage inflammatory protein 2o
01/09/1992CA2086088A1 Human macrophage inflammatory protein 2.beta.
01/09/1992CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
01/09/1992CA2084413A1 Compositions and methods for the prevention and diagnosis of lyme disease
01/09/1992CA2064555A1 Probes for detecting mutant p53
01/08/1992EP0465415A2 Monoclonal antibodies to mycosphaerella species
01/08/1992EP0465404A2 Peptdidylhydroxylglycine N-C lyase and DNA coding therefor
01/08/1992EP0465047A2 Modified tryptophan promoters